IXICO plc Director/PDMR Shareholdings
28 Oktober 2024 - 12:00PM
RNS Regulatory News
RNS Number : 8839J
IXICO plc
28 October 2024
28 October
2024
IXICO PLC
("IXICO" or
the "Company")
Director/PDMR Share
Dealings
Further to the announcements made on
8 October 2024 and 25 October 2024, and pursuant to the recent
fundraising, the Company confirms that the following directors of
the Company have subscribed for New Ordinary Shares at the Issue
Price of 9.5 pence per Ordinary Share as follows:
|
Director/PDMR Name
|
No.
of New Ordinary Shares Subscribed
|
Resultant Shareholding post transaction
|
%
of voting rights post transaction
|
|
Bram Goorden
|
526,315
|
526,315
|
0.6%
|
|
Grant Nash
|
105,263
|
505,263
|
0.5%
|
|
Dipti Amin
|
105,263
|
105,263
|
0.1%
|
|
Katherine Rogers
|
52,631
|
52,631
|
0.1%
|
For
further information please contact:
|
IXICO plc
|
+44 (0) 20 3763 7499
|
|
Bram Goorden, Chief Executive
Officer
Grant Nash, Chief Financial
Officer
|
|
|
|
|
|
Cavendish Capital Markets Limited
(Nominated adviser and sole broker)
|
+44 (0) 20 7220 0500
|
|
Giles Balleny / Dan
Hodkinson (Corporate
Finance)
|
|
|
Nigel Birks (Life Sciences
Specialist Sales)
|
|
|
Harriet Ward (Corporate
Broking)
|
|
|
Michael F Johnson / Tamar Cranford
Smith (Sales)
|
|
About IXICO
IXICO is dedicated to
delivering insights in neuroscience to help transform the
advancement of investigational therapies for neurological diseases,
such as Huntington's disease, Parkinson's disease and Alzheimer's
disease. The Company's purpose is to advance medicine and human
health by turning data into clinically meaningful information,
providing valuable new insights in neuroscience by supporting
pharmaceutical companies across all phases of CNS clinical
research. IXICO's goal is to be a leading advocate of
artificial intelligence in medical image analysis.
IXICO has developed and
deployed breakthrough data analytics, at scale, through its remote
access technology platform, to improve the return on investment in
drug development and reduce risk and uncertainty in clinical trials
for the Company's pharmaceutical clients.
More information is available
on www.IXICO.com and follow us on X
(formerly Twitter) @IXICOnews
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Bram Goorden
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Executive Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
IXICO plc
|
|
b)
|
LEI
|
2138005M1F59O6HWSA97
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
|
Ordinary shares in IXICO
plc
|
|
|
|
|
Identification code
|
ISIN: GB00BFXR4C20
|
|
|
|
|
b)
|
Nature of the transaction
|
Subscription for Ordinary
shares
|
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
9.5 pence
|
526,315
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
N/A - single transaction
|
|
- Aggregated volume
|
|
|
|
|
|
- Price
|
|
|
|
|
|
e)
|
Date of the transaction
|
28 October 2024
|
|
f)
|
Place of the transaction
|
Off Market Transaction
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Grant Nash
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Financial Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
IXICO plc
|
|
b)
|
LEI
|
2138005M1F59O6HWSA97
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
|
Ordinary shares in IXICO
plc
|
|
|
|
|
Identification code
|
ISIN: GB00BFXR4C20
|
|
|
|
|
b)
|
Nature of the transaction
|
Subscription for Ordinary
shares
|
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
9.5 pence
|
105,263
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
N/A - single transaction
|
|
- Aggregated volume
|
|
|
|
|
|
- Price
|
|
|
|
|
|
e)
|
Date of the transaction
|
28 October 2024
|
|
f)
|
Place of the transaction
|
Off Market Transaction
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Dipti Amin
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
IXICO plc
|
|
b)
|
LEI
|
2138005M1F59O6HWSA97
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
|
Ordinary shares in IXICO
plc
|
|
|
|
|
Identification code
|
ISIN: GB00BFXR4C20
|
|
|
|
|
b)
|
Nature of the transaction
|
Subscription for Ordinary
shares
|
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
9.5 pence
|
105,263
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
N/A - single transaction
|
|
- Aggregated volume
|
|
|
|
|
|
- Price
|
|
|
|
|
|
e)
|
Date of the transaction
|
28 October 2024
|
|
f)
|
Place of the transaction
|
Off Market Transaction
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Katherine Rogers
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
IXICO plc
|
|
b)
|
LEI
|
2138005M1F59O6HWSA97
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
|
Ordinary shares in IXICO
plc
|
|
|
|
|
Identification code
|
ISIN: GB00BFXR4C20
|
|
|
|
|
b)
|
Nature of the transaction
|
Subscription for Ordinary
shares
|
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
9.5 pence
|
52,631
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
N/A - single transaction
|
|
- Aggregated volume
|
|
|
|
|
|
- Price
|
|
|
|
|
|
e)
|
Date of the transaction
|
28 October 2024
|
|
f)
|
Place of the transaction
|
Off Market Transaction
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHBGBDGXUDDGSI
Ixico (LSE:IXI)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Ixico (LSE:IXI)
Historical Stock Chart
Von Nov 2023 bis Nov 2024
